@prefix ns1: <http://example.org/> .
@prefix ns2: <http://example.org/relation/> .

<http://example.org/doc/samplepdf> a ns1:Document ;
    ns1:contains <http://example.org/entity/2017_SIOP_2001_analysis_Study>,
        <http://example.org/entity/60_month_EFS_500_ml_data_point>,
        <http://example.org/entity/60_month_EFS_AVD_500_ml_Outcome>,
        <http://example.org/entity/60_month_EFS_AV_2_500_ml_Outcome>,
        <http://example.org/entity/60_month_OS_500_ml_data_point>,
        <http://example.org/entity/60_month_OS_AVD_500_ml_Outcome>,
        <http://example.org/entity/60_month_OS_AV_2_500_ml_Outcome>,
        <http://example.org/entity/AREN0533_trial_clinical_trial>,
        <http://example.org/entity/ASCR_procedure>,
        <http://example.org/entity/AVD150_medication_regimen>,
        <http://example.org/entity/AVD250_medication_regimen>,
        <http://example.org/entity/AVD_500_ml_Treatment_Group>,
        <http://example.org/entity/AV_2_500_ml_Treatment_Group>,
        <http://example.org/entity/Actinomycin_D_medication>,
        <http://example.org/entity/Albania_Country>,
        <http://example.org/entity/Algeria_Country>,
        <http://example.org/entity/Andorra_Country>,
        <http://example.org/entity/Armand_Trousseau_Hospital_Institution>,
        <http://example.org/entity/Arnauld_Verschuur_person>,
        <http://example.org/entity/Austria_Country>,
        <http://example.org/entity/Azienda_Ospedaliera_Institution>,
        <http://example.org/entity/Belarus_Country>,
        <http://example.org/entity/Belgium_Country>,
        <http://example.org/entity/Bilateral_Disease_Stage_V_Condition>,
        <http://example.org/entity/Bosnia_and_Herzegovina_Country>,
        <http://example.org/entity/Breslow_N_E_author>,
        <http://example.org/entity/Bulgaria_Country>,
        <http://example.org/entity/CCSK_Disease>,
        <http://example.org/entity/CDCV_medication_regimen>,
        <http://example.org/entity/CMN_Disease>,
        <http://example.org/entity/COGNWTS_trials_Study>,
        <http://example.org/entity/COG_National_Wilms_Tumor_Study_Group_organization>,
        <http://example.org/entity/CONSENSUS_STATEMENT_document_section>,
        <http://example.org/entity/CT_diagnostic_test>,
        <http://example.org/entity/CT_diagnostic_tool>,
        <http://example.org/entity/CT_only_nodules_medical_term>,
        <http://example.org/entity/Childrens_Oncology_Group_COG_organization>,
        <http://example.org/entity/Childrens_Oncology_Group_organization>,
        <http://example.org/entity/Croatia_Country>,
        <http://example.org/entity/Czech_Republic_Country>,
        <http://example.org/entity/DAngio_G_J_author>,
        <http://example.org/entity/Davila_Fajardo_Author>,
        <http://example.org/entity/Daw_N_C_author>,
        <http://example.org/entity/December_2017_date>,
        <http://example.org/entity/Denmark_Country>,
        <http://example.org/entity/Department_of_Paediatric_Oncology_Organization>,
        <http://example.org/entity/Dix_D_B_author>,
        <http://example.org/entity/Dome_J_S_author>,
        <http://example.org/entity/Doxorubicin_medication>,
        <http://example.org/entity/EFS_Metric>,
        <http://example.org/entity/EFS_Probability_Metric>,
        <http://example.org/entity/EFS_outcome_measure>,
        <http://example.org/entity/Estonia_Country>,
        <http://example.org/entity/European_Expert_Paediatric_Oncology_Reference_Network_for_Diagnostics_and_Treatment_Network>,
        <http://example.org/entity/ExPO_r_Net_Network>,
        <http://example.org/entity/Faculty_of_Medicine_Institution>,
        <http://example.org/entity/Figure_2_figure>,
        <http://example.org/entity/Finland_Country>,
        <http://example.org/entity/Fondazione_IRCCS_Istituto_Nazionale_dei_Tumori_Institution>,
        <http://example.org/entity/France_Country>,
        <http://example.org/entity/Furtwangler_R_author>,
        <http://example.org/entity/Germany_Country>,
        <http://example.org/entity/Graf_N_author>,
        <http://example.org/entity/Great_Ormond_Street_Hospital_Institution>,
        <http://example.org/entity/Greece_Country>,
        <http://example.org/entity/Green_D_M_author>,
        <http://example.org/entity/Grundy_P_E_author>,
        <http://example.org/entity/HR_statistic>,
        <http://example.org/entity/Ha_T_C_author>,
        <http://example.org/entity/Hospital_Universitario_Virgin_del_Rocio_Institution>,
        <http://example.org/entity/Hospital_Vall_dHebron_Institution>,
        <http://example.org/entity/Hungary_Country>,
        <http://example.org/entity/Iceland_Country>,
        <http://example.org/entity/Innovative_Therapies_for_Children_with_Cancer_consortium_organization>,
        <http://example.org/entity/International_Society_of_Paediatric_Oncology_Renal_Tumour_Study_Group_Organization>,
        <http://example.org/entity/Ireland_Country>,
        <http://example.org/entity/Italy_Country>,
        <http://example.org/entity/Kremens_B_author>,
        <http://example.org/entity/LInstitut_dH%C3%A9matologie_et_dOncologie_P%C3%A9diatrique_de_Lyon_Institution>,
        <http://example.org/entity/Latvia_Country>,
        <http://example.org/entity/Liechtenstein_Country>,
        <http://example.org/entity/Lithuania_Country>,
        <http://example.org/entity/LogRank_P_Statistic>,
        <http://example.org/entity/LogRank_P_statistic>,
        <http://example.org/entity/Luxembourg_Country>,
        <http://example.org/entity/MRI_diagnostic_tool>,
        <http://example.org/entity/MRTK_Disease>,
        <http://example.org/entity/Macedonia_Country>,
        <http://example.org/entity/Macmillan_Publishers_Limited_Organization>,
        <http://example.org/entity/Macmillan_Publishers_Limited_organization>,
        <http://example.org/entity/Malta_Country>,
        <http://example.org/entity/Marciniak_Hospital_Institution>,
        <http://example.org/entity/Marry_M_van_den_Heuvel_Eibrink_Person>,
        <http://example.org/entity/Mitchell_C_author>,
        <http://example.org/entity/Moldova_Country>,
        <http://example.org/entity/Monaco_Country>,
        <http://example.org/entity/Montenegro_Country>,
        <http://example.org/entity/Morocco_Country>,
        <http://example.org/entity/NWTS_Study>,
        <http://example.org/entity/National_Wilms_Tumor_Study_Group_organization>,
        <http://example.org/entity/Norway_Country>,
        <http://example.org/entity/OS_Metric>,
        <http://example.org/entity/OS_Probability_Metric>,
        <http://example.org/entity/OS_outcome_measure>,
        <http://example.org/entity/Ospedale_Pediatrico_Bambino_Ges%C3%B9_Institution>,
        <http://example.org/entity/Poland_Country>,
        <http://example.org/entity/Portugal_Country>,
        <http://example.org/entity/Princess_M%C3%A1xima_Center_for_Paediatric_Oncology_Organization>,
        <http://example.org/entity/Prinses_Maxima_Centrum_Institution>,
        <http://example.org/entity/Pritchard_Jones_K_author>,
        <http://example.org/entity/RCC_Disease>,
        <http://example.org/entity/Renal_Tumour_Study_Group_of_the_International_Society_of_Paediatric_Oncology_Organization>,
        <http://example.org/entity/Romania_Country>,
        <http://example.org/entity/Russia_Country>,
        <http://example.org/entity/SIOP2001_Trial>,
        <http://example.org/entity/SIOP2001_medical_study>,
        <http://example.org/entity/SIOP2001_protocol_Protocol>,
        <http://example.org/entity/SIOP2001_randomized_controlled_trial_clinical_trial>,
        <http://example.org/entity/SIOP2001_randomized_trial_trial>,
        <http://example.org/entity/SIOP9301_Trial>,
        <http://example.org/entity/SIOPRTSG_2016_Protocol>,
        <http://example.org/entity/SIOPRTSG_Acronym>,
        <http://example.org/entity/SIOPRTSG_analysis_analysis>,
        <http://example.org/entity/SIOPRTSG_board_organization>,
        <http://example.org/entity/SIOPRTSG_organization>,
        <http://example.org/entity/SIOPRTSG_panel_organization>,
        <http://example.org/entity/SIOP_2001_Study>,
        <http://example.org/entity/SIOP_9301_trial_study>,
        <http://example.org/entity/SIOP_9GPOH_study>,
        <http://example.org/entity/SIOP_Renal_Tumor_Study_Group_organization>,
        <http://example.org/entity/SIOP_Renal_Tumour_Study_Group_Group>,
        <http://example.org/entity/SIOP_database_database>,
        <http://example.org/entity/San_Marino_Country>,
        <http://example.org/entity/Serbia_Country>,
        <http://example.org/entity/Slovakia_Country>,
        <http://example.org/entity/Slovenia_Country>,
        <http://example.org/entity/Smets_A_M_author>,
        <http://example.org/entity/Spain_Country>,
        <http://example.org/entity/Spreafico_F_author>,
        <http://example.org/entity/Springer_Nature_Organization>,
        <http://example.org/entity/Springer_Nature_organization>,
        <http://example.org/entity/St_Anna_KinderspitalCCRI_Institution>,
        <http://example.org/entity/Stage_IIIII_intermediate_risk_Wilms_tumours_Condition>,
        <http://example.org/entity/Stage_IV_WT_condition>,
        <http://example.org/entity/Stage_IV_disease_Condition>,
        <http://example.org/entity/Sweden_Country>,
        <http://example.org/entity/Switzerland_Country>,
        <http://example.org/entity/Synchronous_bilateral_Wilms_tumour_stage_V_Subcondition>,
        <http://example.org/entity/Tournade_M_F_author>,
        <http://example.org/entity/Tunisia_Country>,
        <http://example.org/entity/Turkey_Country>,
        <http://example.org/entity/UKW3_trial_study>,
        <http://example.org/entity/UKW3_trial_trial>,
        <http://example.org/entity/UK_Childrens_Cancer_and_Leukaemia_Group_UKCCLG_organization>,
        <http://example.org/entity/UMBRELLA_Protocol_protocol>,
        <http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_Protocol>,
        <http://example.org/entity/UMBRELLA_protocol_Protocol>,
        <http://example.org/entity/UMBRELLA_protocol_medical_protocol>,
        <http://example.org/entity/UMBRELLA_protocol_protocol>,
        <http://example.org/entity/Ukraine_Country>,
        <http://example.org/entity/United_Kingdom_Country>,
        <http://example.org/entity/University_Hospital_Homburg_Institution>,
        <http://example.org/entity/University_Hospital_of_Munich_Institution>,
        <http://example.org/entity/University_Hospital_of_Tuebingen_Institution>,
        <http://example.org/entity/VP16_medication>,
        <http://example.org/entity/Verschuur_A_author>,
        <http://example.org/entity/Vincristine_medication>,
        <http://example.org/entity/Warmann_S_W_author>,
        <http://example.org/entity/Weirich_A_author>,
        <http://example.org/entity/Wilms_Tumours_disease>,
        <http://example.org/entity/Wilms_tumour_Disease>,
        <http://example.org/entity/Wilms_tumours_Condition>,
        <http://example.org/entity/Wilms_tumours_Medical_Condition>,
        <http://example.org/entity/actinomycin_D_Drug>,
        <http://example.org/entity/actinomycin_D_Medication>,
        <http://example.org/entity/actinomycin_D_medication>,
        <http://example.org/entity/adult_Wilms_Tumours_medical_condition>,
        <http://example.org/entity/anaplasia_medical_condition>,
        <http://example.org/entity/autologous_stem_cell_transplantation_treatment>,
        <http://example.org/entity/blastemal_type_tumors_condition>,
        <http://example.org/entity/blastemal_type_tumours_Condition>,
        <http://example.org/entity/camptothecins_medication>,
        <http://example.org/entity/carboplatin_Drug>,
        <http://example.org/entity/carboplatin_medication>,
        <http://example.org/entity/chemotherapy_treatment>,
        <http://example.org/entity/childhood_renal_tumours_Medical_Condition>,
        <http://example.org/entity/clear_cell_sarcoma_of_the_kidney_Medical_Condition>,
        <http://example.org/entity/congenital_mesoblastic_nephroma_Medical_Condition>,
        <http://example.org/entity/congenital_mesoblastic_nephroma_medical_condition>,
        <http://example.org/entity/cyclophosphamide_Drug>,
        <http://example.org/entity/cyclophosphamide_medication>,
        <http://example.org/entity/de_Kraker_J_author>,
        <http://example.org/entity/diffuse_anaplasia_condition>,
        <http://example.org/entity/doxorubicin_Drug>,
        <http://example.org/entity/doxorubicin_Medication>,
        <http://example.org/entity/doxorubicin_medication>,
        <http://example.org/entity/etoposide_Drug>,
        <http://example.org/entity/etoposide_medication>,
        <http://example.org/entity/group_BB_protocol_protocol>,
        <http://example.org/entity/ifosfamide_medication>,
        <http://example.org/entity/infant_Wilms_Tumours_medical_condition>,
        <http://example.org/entity/irinotecan_medication>,
        <http://example.org/entity/laparoscopic_surgery_Treatment>,
        <http://example.org/entity/lymph_node_sampling_procedure>,
        <http://example.org/entity/malignant_rhabdoid_tumors_medical_condition>,
        <http://example.org/entity/malignant_rhabdoid_tumour_of_the_kidney_Medical_Condition>,
        <http://example.org/entity/minimally_invasive_surgery_Treatment>,
        <http://example.org/entity/nephrectomy_procedure>,
        <http://example.org/entity/nephron_sparing_surgery_NSS_Treatment>,
        <http://example.org/entity/nephron_sparing_surgery_NSS_procedure>,
        <http://example.org/entity/nephrotoxicity_condition>,
        <http://example.org/entity/non_Wilms_tumours_Medical_Condition>,
        <http://example.org/entity/proton_therapy_Treatment>,
        <http://example.org/entity/pulmonary_metastases_Condition>,
        <http://example.org/entity/pulmonary_radiotherapy_Treatment>,
        <http://example.org/entity/radical_tumor_nephrectomy_procedure>,
        <http://example.org/entity/radiotherapy_Treatment>,
        <http://example.org/entity/radiotherapy_treatment>,
        <http://example.org/entity/relapsed_group_CC_patient_group>,
        <http://example.org/entity/renal_cell_carcinoma_Medical_Condition>,
        <http://example.org/entity/surgery_treatment>,
        <http://example.org/entity/surgical_excision_treatment>,
        <http://example.org/entity/topotecan_medication>,
        <http://example.org/entity/van_den_Heuvel_Eibrink_M_M_author>,
        <http://example.org/entity/vincristine_Medication>,
        <http://example.org/entity/vincristine_and_actinomycin_D_Treatment_Regimen>,
        <http://example.org/entity/vincristine_and_actinomycin_D_plus_doxorubicin_treatment>,
        <http://example.org/entity/vincristine_and_actinomycin_D_treatment>,
        <http://example.org/entity/vincristine_medication>,
        <http://example.org/entity/whole_abdominal_radiotherapy_Treatment>,
        <http://example.org/entity/whole_lung_irradiation_Treatment>,
        <http://example.org/entity/wwwsiop_rtsgeu_Website> .

<http://example.org/entity/AREN0533_trial_entity> ns2:evaluates_cumulative_dose_of <http://example.org/entity/doxorubicin_entity> .

<http://example.org/entity/AVD150_entity> ns2:includes <http://example.org/entity/actinomycin_D_entity>,
        <http://example.org/entity/doxorubicin_entity>,
        <http://example.org/entity/vincristine_entity> .

<http://example.org/entity/Actinomycin_D_entity> ns2:is_used_to_treat <http://example.org/entity/Wilms_Tumours_entity> .

<http://example.org/entity/Armand_Trousseau_Hospital_entity> ns2:located_in <http://example.org/entity/France_entity> .

<http://example.org/entity/Azienda_Ospedaliera_entity> ns2:located_in <http://example.org/entity/Italy_entity> .

<http://example.org/entity/Breslow_N_E_entity> ns2:researched <http://example.org/entity/National_Wilms_Tumor_Studies_entity> .

<http://example.org/entity/CCSK_entity> ns2:included_in <http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_protocol_logo_entity> .

<http://example.org/entity/CDCV_entity> ns2:includes <http://example.org/entity/VP16_entity>,
        <http://example.org/entity/carboplatin_entity>,
        <http://example.org/entity/cyclophosphamide_entity>,
        <http://example.org/entity/doxorubicin_entity> .

<http://example.org/entity/CMN_entity> ns2:included_in <http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_protocol_logo_entity> .

<http://example.org/entity/CT_entity> ns2:used_for_assessment_in <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/CT_only_nodules_entity> ns2:included_in <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/Childrens_Oncology_Group_COG_entity> ns2:provided_expertise_for <http://example.org/entity/SIOP2001_randomized_trial_entity> .

<http://example.org/entity/DAngio_G_J_entity> ns2:presented_results <http://example.org/entity/Third_National_Wilms_Tumor_Study_entity> .

<http://example.org/entity/Davila_Fajardo_entity> ns2:author_of <http://example.org/entity/2017_SIOP_2001_analysis_entity> .

<http://example.org/entity/Daw_N_C_entity> ns2:conducted_study <http://example.org/entity/Childrens_Oncology_Group_AREN0321_study_entity> .

<http://example.org/entity/December_2017_entity> ns2:date_of_publication <http://example.org/entity/CONSENSUS_STATEMENT_entity> .

<http://example.org/entity/Dix_D_B_entity> ns2:reported_on <http://example.org/entity/Childrens_Oncology_Group_study_AREN0533_entity> .

<http://example.org/entity/Dome_J_S_entity> ns2:discussed_progress <http://example.org/entity/international_collaboration_entity> .

<http://example.org/entity/Doxorubicin_entity> ns2:is_used_to_treat <http://example.org/entity/Wilms_Tumours_entity> .

<http://example.org/entity/ExPO_r_Net_entity> ns2:part_of <http://example.org/entity/European_Expert_Paediatric_Oncology_Reference_Network_for_Diagnostics_and_Treatment_entity> .

<http://example.org/entity/Faculty_of_Medicine_entity> ns2:located_in <http://example.org/entity/Poland_entity> .

<http://example.org/entity/Fondazione_IRCCS_Istituto_Nazionale_dei_Tumori_entity> ns2:located_in <http://example.org/entity/Italy_entity> .

<http://example.org/entity/Furtwangler_R_entity> ns2:updated_on_relapses <http://example.org/entity/SIOPGPOH_studies_entity> .

<http://example.org/entity/Great_Ormond_Street_Hospital_entity> ns2:located_in <http://example.org/entity/United_Kingdom_entity> .

<http://example.org/entity/Green_D_M_entity> ns2:reported_to <http://example.org/entity/National_Wilms_Tumor_Study_Group_entity> .

<http://example.org/entity/Grundy_P_E_entity> ns2:contributed_to <http://example.org/entity/Childrens_Oncology_Group_entity> .

<http://example.org/entity/Ha_T_C_entity> ns2:desired_to_determine <http://example.org/entity/international_strategy_entity> .

<http://example.org/entity/Hospital_Universitario_Virgin_del_Rocio_entity> ns2:located_in <http://example.org/entity/Spain_entity> .

<http://example.org/entity/Hospital_Vall_dHebron_entity> ns2:located_in <http://example.org/entity/Spain_entity> .

<http://example.org/entity/Kremens_B_entity> ns2:researched_effectiveness <http://example.org/entity/high_dose_chemotherapy_entity> .

<http://example.org/entity/LInstitut_dH%C3%A9matologie_et_dOncologie_P%C3%A9diatrique_de_Lyon_entity> ns2:located_in <http://example.org/entity/France_entity> .

<http://example.org/entity/LogRank_P_00005_entity> ns2:associated_with <http://example.org/entity/60_month_EFS_entity> .

<http://example.org/entity/LogRank_P_01_entity> ns2:associated_with <http://example.org/entity/60_month_OS_entity> .

<http://example.org/entity/MRI_entity> ns2:used_for_assessment_in <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/MRTK_entity> ns2:included_in <http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_protocol_logo_entity> .

<http://example.org/entity/Macmillan_Publishers_Limited_entity> ns2:part_of <http://example.org/entity/Springer_Nature_entity> .

<http://example.org/entity/Marciniak_Hospital_entity> ns2:located_in <http://example.org/entity/Poland_entity> .

<http://example.org/entity/Marry_M_van_den_Heuvel_Eibrink_entity> ns2:part_of <http://example.org/entity/International_Society_of_Paediatric_Oncology_Renal_Tumour_Study_Group_entity> ;
    ns2:works_at <http://example.org/entity/Princess_M%C3%A1xima_Center_for_Paediatric_Oncology_entity> .

<http://example.org/entity/Mitchell_C_entity> ns2:led_trial <http://example.org/entity/UKW3_entity> .

<http://example.org/entity/Ospedale_Pediatrico_Bambino_Ges%C3%B9_entity> ns2:located_in <http://example.org/entity/Italy_entity> .

<http://example.org/entity/Prinses_Maxima_Centrum_entity> ns2:located_in <http://example.org/entity/Netherlands_entity> .

<http://example.org/entity/Pritchard_Jones_K_entity> ns2:analyzed <http://example.org/entity/UKW3_trial_entity> .

<http://example.org/entity/RCC_entity> ns2:included_in <http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_protocol_logo_entity> .

<http://example.org/entity/SIOP2001_randomized_controlled_trial_entity> ns2:results_featured_in <http://example.org/entity/Figure_2_entity> .

<http://example.org/entity/SIOPRTSG_2016_entity> ns2:part_of <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/SIOPRTSG_entity> ns2:developed <http://example.org/entity/UMBRELLA_Protocol_entity> ;
    ns2:developed_classification_for <http://example.org/entity/NSS_entity> ;
    ns2:is <http://example.org/entity/Renal_Tumour_Study_Group_of_the_International_Society_of_Paediatric_Oncology_entity> .

<http://example.org/entity/SIOPRTSG_panel_entity> ns2:associated_with <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/St_Anna_KinderspitalCCRI_entity> ns2:located_in <http://example.org/entity/Austria_entity> .

<http://example.org/entity/Synchronous_bilateral_Wilms_tumour_stage_V_entity> ns2:instance_of <http://example.org/entity/Bilateral_Disease_Stage_V_entity> ;
    ns2:prevalence <http://example.org/entity/58_entity> .

<http://example.org/entity/Tournade_M_F_entity> ns2:contributed_to <http://example.org/entity/Ninth_International_Society_of_Pediatric_Oncology_Wilms_Tumor_Trial_and_Study_entity> .

<http://example.org/entity/UK_Childrens_Cancer_and_Leukaemia_Group_UKCCLG_entity> ns2:conducted <http://example.org/entity/UKW3_trial_entity> .

<http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_entity> ns2:addresses <http://example.org/entity/childhood_renal_tumours_entity> ;
    ns2:succeeds <http://example.org/entity/SIOP2001_protocol_entity> .

<http://example.org/entity/University_Hospital_Homburg_entity> ns2:located_in <http://example.org/entity/Germany_entity> .

<http://example.org/entity/University_Hospital_of_Munich_entity> ns2:located_in <http://example.org/entity/Germany_entity> .

<http://example.org/entity/University_Hospital_of_Tuebingen_entity> ns2:located_in <http://example.org/entity/Germany_entity> .

<http://example.org/entity/Verschuur_A_entity> ns2:participated_in <http://example.org/entity/SIOP_93_01_entity> .

<http://example.org/entity/Vincristine_entity> ns2:is_used_to_treat <http://example.org/entity/Wilms_Tumours_entity> .

<http://example.org/entity/Warmann_S_W_entity> ns2:studied_outcome <http://example.org/entity/SIOP_93_01GPOH_entity> .

<http://example.org/entity/Weirich_A_entity> ns2:contributed_to <http://example.org/entity/SIOP_9GPOH_entity> .

<http://example.org/entity/anaplasia_entity> ns2:considered_as <http://example.org/entity/high_risk_subtype_entity> .

<http://example.org/entity/autologous_stem_cell_transplantation_entity> ns2:treatment_option_discussed_by <http://example.org/entity/COG_entity> .

<http://example.org/entity/blastemal_type_tumours_entity> ns2:treatment_regimen_used_in <http://example.org/entity/SIOP2001_entity> .

<http://example.org/entity/chemotherapy_entity> ns2:used_for <http://example.org/entity/reduction_of_relapsed_disease_entity> .

<http://example.org/entity/de_Kraker_J_entity> ns2:studied <http://example.org/entity/SIOP_9301_trial_entity> .

<http://example.org/entity/etoposide_entity> ns2:used_for <http://example.org/entity/anaplastic_tumors_entity> .

<http://example.org/entity/group_BB_protocol_entity> ns2:alternates_with <http://example.org/entity/ifosfamide_entity> ;
    ns2:utilizes <http://example.org/entity/cyclophosphamide_entity> .

<http://example.org/entity/infant_Wilms_Tumours_entity> ns2:considered_for <http://example.org/entity/nephrectomy_entity> .

<http://example.org/entity/irinotecan_cyclophosphamide_carboplatin_etoposide_and_doxorubicin_entity> ns2:suggested_treatment_by <http://example.org/entity/SIOPRTSG_board_entity> .

<http://example.org/entity/laparoscopic_surgery_entity> ns2:addressed_in <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/lymph_node_sampling_entity> ns2:specified_by <http://example.org/entity/umbrella_protocol_entity> .

<http://example.org/entity/malignant_rhabdoid_tumors_entity> ns2:needs <http://example.org/entity/alternative_chemotherapy_entity> .

<http://example.org/entity/minimally_invasive_surgery_entity> ns2:addressed_in <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/nephron_sparing_surgery_NSS_entity> ns2:acceptable_for <http://example.org/entity/nonsyndromic_unilateral_Wilms_tumors_entity> ;
    ns2:related_to <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/non_Wilms_tumours_entity> ns2:includes <http://example.org/entity/clear_cell_sarcoma_of_the_kidney_entity>,
        <http://example.org/entity/congenital_mesoblastic_nephroma_entity>,
        <http://example.org/entity/malignant_rhabdoid_tumour_of_the_kidney_entity>,
        <http://example.org/entity/renal_cell_carcinoma_entity> .

<http://example.org/entity/proton_therapy_entity> ns2:investigation_for <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/pulmonary_metastases_entity> ns2:is_a_manifestation_of <http://example.org/entity/Stage_IV_disease_entity> .

<http://example.org/entity/radical_tumor_nephrectomy_entity> ns2:standard_care_for <http://example.org/entity/children_with_Wilms_tumor_entity> .

<http://example.org/entity/radiotherapy_entity> ns2:guided_by <http://example.org/entity/UMBRELLA_protocol_entity> ;
    ns2:used_for <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/radiotherapy_guidelines_entity> ns2:refined_in <http://example.org/entity/SIOP_2001_entity> .

<http://example.org/entity/relapsed_group_CC_entity> ns2:advises_trying <http://example.org/entity/camptothecins_entity> .

<http://example.org/entity/van_den_Heuvel_Eibrink_M_M_entity> ns2:reported_results <http://example.org/entity/SIOP_Renal_Tumor_Study_Group_entity> .

<http://example.org/entity/vincristine_actinomycin_D_and_doxorubicin_entity> ns2:part_of_preoperative_treatment_in <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/vincristine_and_actinomycin_D_entity> ns2:evaluated_by <http://example.org/entity/COG_National_Wilms_Tumor_Study_Group_entity> .

<http://example.org/entity/vincristine_and_actinomycin_D_plus_doxorubicin_entity> ns2:evaluated_by <http://example.org/entity/COG_National_Wilms_Tumor_Study_Group_entity> .

<http://example.org/entity/vincristine_and_actinomycin_D_without_doxorubicin_entity> ns2:is_treatment_regimen_for <http://example.org/entity/Stage_IIIII_intermediate_risk_Wilms_tumours_entity> .

<http://example.org/entity/whole_lung_irradiation_entity> ns2:aligned_with <http://example.org/entity/NWTS_experience_entity> .

<http://example.org/entity/2017_SIOP_2001_analysis_Study> a ns1:Study ;
    ns1:name "2017 SIOP-2001 analysis" .

<http://example.org/entity/2017_SIOP_2001_analysis_entity> ns2:based_on <http://example.org/entity/SIOP_2001_entity> .

<http://example.org/entity/60_month_EFS_500_ml_data_point> a ns1:data_point ;
    ns1:name "60-month EFS – 500+ ml",
        "60-month EFS – <500 ml" .

<http://example.org/entity/60_month_EFS_AVD_500_ml_Outcome> a ns1:Outcome ;
    ns1:name "60-month EFS - AVD (500+ ml)",
        "60-month EFS - AVD (<500 ml)" .

<http://example.org/entity/60_month_EFS_AV_2_500_ml_Outcome> a ns1:Outcome ;
    ns1:name "60-month EFS - AV-2 (500+ ml)",
        "60-month EFS - AV-2 (<500 ml)" .

<http://example.org/entity/60_month_OS_500_ml_data_point> a ns1:data_point ;
    ns1:name "60-month OS – 500+ ml",
        "60-month OS – <500 ml" .

<http://example.org/entity/60_month_OS_AVD_500_ml_Outcome> a ns1:Outcome ;
    ns1:name "60-month OS - AVD (500+ ml)",
        "60-month OS - AVD (<500 ml)" .

<http://example.org/entity/60_month_OS_AV_2_500_ml_Outcome> a ns1:Outcome ;
    ns1:name "60-month OS - AV-2 (500+ ml)",
        "60-month OS - AV-2 (<500 ml)" .

<http://example.org/entity/AREN0533_trial_clinical_trial> a ns1:clinical_trial ;
    ns1:name "AREN0533 trial" .

<http://example.org/entity/ASCR_procedure> a ns1:procedure ;
    ns1:name "ASCR" .

<http://example.org/entity/AVD150_medication_regimen> a ns1:medication_regimen ;
    ns1:name "AVD150" .

<http://example.org/entity/AVD250_medication_regimen> a ns1:medication_regimen ;
    ns1:name "AVD250" .

<http://example.org/entity/AVD_500_ml_Treatment_Group> a ns1:Treatment_Group ;
    ns1:name "AVD (500+ ml)",
        "AVD (<500 ml)" .

<http://example.org/entity/AV_2_500_ml_Treatment_Group> a ns1:Treatment_Group ;
    ns1:name "AV-2 (500+ ml)",
        "AV-2 (<500 ml)" .

<http://example.org/entity/Actinomycin_D_medication> a ns1:medication ;
    ns1:name "Actinomycin D" .

<http://example.org/entity/Albania_Country> a ns1:Country ;
    ns1:name "Albania" .

<http://example.org/entity/Algeria_Country> a ns1:Country ;
    ns1:name "Algeria" .

<http://example.org/entity/Andorra_Country> a ns1:Country ;
    ns1:name "Andorra" .

<http://example.org/entity/Armand_Trousseau_Hospital_Institution> a ns1:Institution ;
    ns1:name "Armand Trousseau Hospital" .

<http://example.org/entity/Arnauld_Verschuur_person> a ns1:person ;
    ns1:name "Arnauld Verschuur" .

<http://example.org/entity/Austria_Country> a ns1:Country ;
    ns1:name "Austria" .

<http://example.org/entity/Azienda_Ospedaliera_Institution> a ns1:Institution ;
    ns1:name "Azienda Ospedaliera" .

<http://example.org/entity/Belarus_Country> a ns1:Country ;
    ns1:name "Belarus" .

<http://example.org/entity/Belgium_Country> a ns1:Country ;
    ns1:name "Belgium" .

<http://example.org/entity/Bilateral_Disease_Stage_V_Condition> a ns1:Condition ;
    ns1:name "Bilateral Disease (Stage V)" .

<http://example.org/entity/Bilateral_Disease_Stage_V_entity> ns2:associated_with <http://example.org/entity/Wilms_tumour_entity> ;
    ns2:long_term_overall_survival <http://example.org/entity/80_entity> .

<http://example.org/entity/Bosnia_and_Herzegovina_Country> a ns1:Country ;
    ns1:name "Bosnia and Herzegovina" .

<http://example.org/entity/Breslow_N_E_author> a ns1:author ;
    ns1:name "Breslow, N. E." .

<http://example.org/entity/Bulgaria_Country> a ns1:Country ;
    ns1:name "Bulgaria" .

<http://example.org/entity/CCSK_Disease> a ns1:Disease ;
    ns1:name "CCSK" .

<http://example.org/entity/CDCV_medication_regimen> a ns1:medication_regimen ;
    ns1:name "CDCV" .

<http://example.org/entity/CMN_Disease> a ns1:Disease ;
    ns1:name "CMN" .

<http://example.org/entity/COGNWTS_trials_Study> a ns1:Study ;
    ns1:name "COG–NWTS trials" .

<http://example.org/entity/COG_National_Wilms_Tumor_Study_Group_organization> a ns1:organization ;
    ns1:name "COG National Wilms Tumor Study Group" .

<http://example.org/entity/CONSENSUS_STATEMENT_document_section> a ns1:document_section ;
    ns1:name "CONSENSUS STATEMENT" .

<http://example.org/entity/CT_diagnostic_test> a ns1:diagnostic_test ;
    ns1:name "CT" .

<http://example.org/entity/CT_diagnostic_tool> a ns1:diagnostic_tool ;
    ns1:name "CT" .

<http://example.org/entity/CT_only_nodules_medical_term> a ns1:medical_term ;
    ns1:name "CT-only nodules" .

<http://example.org/entity/Childrens_Oncology_Group_COG_organization> a ns1:organization ;
    ns1:name "Children’s Oncology Group (COG)" .

<http://example.org/entity/Childrens_Oncology_Group_organization> a ns1:organization ;
    ns1:name "Children's Oncology Group" .

<http://example.org/entity/Croatia_Country> a ns1:Country ;
    ns1:name "Croatia" .

<http://example.org/entity/Czech_Republic_Country> a ns1:Country ;
    ns1:name "Czech Republic" .

<http://example.org/entity/DAngio_G_J_author> a ns1:author ;
    ns1:name "D’Angio, G. J." .

<http://example.org/entity/Davila_Fajardo_Author> a ns1:Author ;
    ns1:name "Davila Fajardo" .

<http://example.org/entity/Daw_N_C_author> a ns1:author ;
    ns1:name "Daw, N. C." .

<http://example.org/entity/December_2017_date> a ns1:date ;
    ns1:name "December 2017" .

<http://example.org/entity/Denmark_Country> a ns1:Country ;
    ns1:name "Denmark" .

<http://example.org/entity/Department_of_Paediatric_Oncology_Organization> a ns1:Organization ;
    ns1:name "Department of Paediatric Oncology" .

<http://example.org/entity/Dix_D_B_author> a ns1:author ;
    ns1:name "Dix, D. B." .

<http://example.org/entity/Dome_J_S_author> a ns1:author ;
    ns1:name "Dome, J. S." .

<http://example.org/entity/Doxorubicin_medication> a ns1:medication ;
    ns1:name "Doxorubicin" .

<http://example.org/entity/EFS_Metric> a ns1:Metric ;
    ns1:name "EFS" .

<http://example.org/entity/EFS_Probability_Metric> a ns1:Metric ;
    ns1:name "EFS Probability" .

<http://example.org/entity/EFS_outcome_measure> a ns1:outcome_measure ;
    ns1:name "EFS" .

<http://example.org/entity/Estonia_Country> a ns1:Country ;
    ns1:name "Estonia" .

<http://example.org/entity/European_Expert_Paediatric_Oncology_Reference_Network_for_Diagnostics_and_Treatment_Network> a ns1:Network ;
    ns1:name "European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment" .

<http://example.org/entity/ExPO_r_Net_Network> a ns1:Network ;
    ns1:name "ExPO-r-Net" .

<http://example.org/entity/Faculty_of_Medicine_Institution> a ns1:Institution ;
    ns1:name "Faculty of Medicine" .

<http://example.org/entity/Figure_2_figure> a ns1:figure ;
    ns1:name "Figure 2" .

<http://example.org/entity/Finland_Country> a ns1:Country ;
    ns1:name "Finland" .

<http://example.org/entity/Fondazione_IRCCS_Istituto_Nazionale_dei_Tumori_Institution> a ns1:Institution ;
    ns1:name "Fondazione IRCCS Istituto Nazionale dei Tumori" .

<http://example.org/entity/France_Country> a ns1:Country ;
    ns1:name "France" .

<http://example.org/entity/Furtwangler_R_author> a ns1:author ;
    ns1:name "Furtwangler, R." .

<http://example.org/entity/Germany_Country> a ns1:Country ;
    ns1:name "Germany" .

<http://example.org/entity/Graf_N_author> a ns1:author ;
    ns1:name "Graf, N." .

<http://example.org/entity/Great_Ormond_Street_Hospital_Institution> a ns1:Institution ;
    ns1:name "Great Ormond Street Hospital" .

<http://example.org/entity/Greece_Country> a ns1:Country ;
    ns1:name "Greece" .

<http://example.org/entity/Green_D_M_author> a ns1:author ;
    ns1:name "Green, D. M." .

<http://example.org/entity/Grundy_P_E_author> a ns1:author ;
    ns1:name "Grundy, P. E." .

<http://example.org/entity/HR_statistic> a ns1:statistic ;
    ns1:name "HR" .

<http://example.org/entity/Ha_T_C_author> a ns1:author ;
    ns1:name "Ha, T. C." .

<http://example.org/entity/Hospital_Universitario_Virgin_del_Rocio_Institution> a ns1:Institution ;
    ns1:name "Hospital Universitario Virgin del Rocio" .

<http://example.org/entity/Hospital_Vall_dHebron_Institution> a ns1:Institution ;
    ns1:name "Hospital Vall d’Hebron" .

<http://example.org/entity/Hungary_Country> a ns1:Country ;
    ns1:name "Hungary" .

<http://example.org/entity/Iceland_Country> a ns1:Country ;
    ns1:name "Iceland" .

<http://example.org/entity/Innovative_Therapies_for_Children_with_Cancer_consortium_organization> a ns1:organization ;
    ns1:name "Innovative Therapies for Children with Cancer consortium" .

<http://example.org/entity/International_Society_of_Paediatric_Oncology_Renal_Tumour_Study_Group_Organization> a ns1:Organization ;
    ns1:name "International Society of Paediatric Oncology — Renal Tumour Study Group" .

<http://example.org/entity/Ireland_Country> a ns1:Country ;
    ns1:name "Ireland" .

<http://example.org/entity/Italy_Country> a ns1:Country ;
    ns1:name "Italy" .

<http://example.org/entity/Kremens_B_author> a ns1:author ;
    ns1:name "Kremens, B." .

<http://example.org/entity/LInstitut_dH%C3%A9matologie_et_dOncologie_P%C3%A9diatrique_de_Lyon_Institution> a ns1:Institution ;
    ns1:name "L’Institut d’Hématologie et d’Oncologie Pédiatrique de Lyon" .

<http://example.org/entity/Latvia_Country> a ns1:Country ;
    ns1:name "Latvia" .

<http://example.org/entity/Liechtenstein_Country> a ns1:Country ;
    ns1:name "Liechtenstein" .

<http://example.org/entity/Lithuania_Country> a ns1:Country ;
    ns1:name "Lithuania" .

<http://example.org/entity/LogRank_P_Statistic> a ns1:Statistic ;
    ns1:name "Log–Rank P" .

<http://example.org/entity/LogRank_P_statistic> a ns1:statistic ;
    ns1:name "Log–Rank P" .

<http://example.org/entity/Luxembourg_Country> a ns1:Country ;
    ns1:name "Luxembourg" .

<http://example.org/entity/MRI_diagnostic_tool> a ns1:diagnostic_tool ;
    ns1:name "MRI" .

<http://example.org/entity/MRTK_Disease> a ns1:Disease ;
    ns1:name "MRTK" .

<http://example.org/entity/Macedonia_Country> a ns1:Country ;
    ns1:name "Macedonia" .

<http://example.org/entity/Macmillan_Publishers_Limited_Organization> a ns1:Organization ;
    ns1:name "Macmillan Publishers Limited" .

<http://example.org/entity/Macmillan_Publishers_Limited_organization> a ns1:organization ;
    ns1:name "Macmillan Publishers Limited" .

<http://example.org/entity/Malta_Country> a ns1:Country ;
    ns1:name "Malta" .

<http://example.org/entity/Marciniak_Hospital_Institution> a ns1:Institution ;
    ns1:name "Marciniak Hospital" .

<http://example.org/entity/Marry_M_van_den_Heuvel_Eibrink_Person> a ns1:Person ;
    ns1:name "Marry M. van den Heuvel-Eibrink" .

<http://example.org/entity/Mitchell_C_author> a ns1:author ;
    ns1:name "Mitchell, C." .

<http://example.org/entity/Moldova_Country> a ns1:Country ;
    ns1:name "Moldova" .

<http://example.org/entity/Monaco_Country> a ns1:Country ;
    ns1:name "Monaco" .

<http://example.org/entity/Montenegro_Country> a ns1:Country ;
    ns1:name "Montenegro" .

<http://example.org/entity/Morocco_Country> a ns1:Country ;
    ns1:name "Morocco" .

<http://example.org/entity/NWTS_Study> a ns1:Study ;
    ns1:name "NWTS" .

<http://example.org/entity/National_Wilms_Tumor_Study_Group_organization> a ns1:organization ;
    ns1:name "National Wilms Tumor Study Group" .

<http://example.org/entity/Norway_Country> a ns1:Country ;
    ns1:name "Norway" .

<http://example.org/entity/OS_Metric> a ns1:Metric ;
    ns1:name "OS" .

<http://example.org/entity/OS_Probability_Metric> a ns1:Metric ;
    ns1:name "OS Probability" .

<http://example.org/entity/OS_outcome_measure> a ns1:outcome_measure ;
    ns1:name "OS" .

<http://example.org/entity/Ospedale_Pediatrico_Bambino_Ges%C3%B9_Institution> a ns1:Institution ;
    ns1:name "Ospedale Pediatrico Bambino Gesù" .

<http://example.org/entity/Poland_Country> a ns1:Country ;
    ns1:name "Poland" .

<http://example.org/entity/Portugal_Country> a ns1:Country ;
    ns1:name "Portugal" .

<http://example.org/entity/Princess_M%C3%A1xima_Center_for_Paediatric_Oncology_Organization> a ns1:Organization ;
    ns1:name "Princess Máxima Center for Paediatric Oncology" .

<http://example.org/entity/Prinses_Maxima_Centrum_Institution> a ns1:Institution ;
    ns1:name "Prinses Maxima Centrum" .

<http://example.org/entity/Pritchard_Jones_K_author> a ns1:author ;
    ns1:name "Pritchard-Jones, K." .

<http://example.org/entity/RCC_Disease> a ns1:Disease ;
    ns1:name "RCC" .

<http://example.org/entity/Renal_Tumour_Study_Group_of_the_International_Society_of_Paediatric_Oncology_Organization> a ns1:Organization ;
    ns1:name "Renal Tumour Study Group of the International Society of Paediatric Oncology" .

<http://example.org/entity/Romania_Country> a ns1:Country ;
    ns1:name "Romania" .

<http://example.org/entity/Russia_Country> a ns1:Country ;
    ns1:name "Russia" .

<http://example.org/entity/SIOP2001_Trial> a ns1:Trial ;
    ns1:name "SIOP−2001" .

<http://example.org/entity/SIOP2001_medical_study> a ns1:medical_study ;
    ns1:name "SIOP−2001" .

<http://example.org/entity/SIOP2001_protocol_Protocol> a ns1:Protocol ;
    ns1:name "SIOP−2001 protocol" .

<http://example.org/entity/SIOP2001_randomized_controlled_trial_clinical_trial> a ns1:clinical_trial ;
    ns1:name "SIOP−2001 randomized controlled trial" .

<http://example.org/entity/SIOP2001_randomized_trial_trial> a ns1:trial ;
    ns1:name "SIOP−2001 randomized trial" .

<http://example.org/entity/SIOP9301_Trial> a ns1:Trial ;
    ns1:name "SIOP−93–01" .

<http://example.org/entity/SIOPRTSG_2016_Protocol> a ns1:Protocol ;
    ns1:name "SIOP–RTSG 2016" .

<http://example.org/entity/SIOPRTSG_Acronym> a ns1:Acronym ;
    ns1:name "SIOP–RTSG" .

<http://example.org/entity/SIOPRTSG_analysis_analysis> a ns1:analysis ;
    ns1:name "SIOP–RTSG analysis" .

<http://example.org/entity/SIOPRTSG_board_organization> a ns1:organization ;
    ns1:name "SIOP–RTSG board" .

<http://example.org/entity/SIOPRTSG_organization> a ns1:organization ;
    ns1:name "SIOP–RTSG" .

<http://example.org/entity/SIOPRTSG_panel_organization> a ns1:organization ;
    ns1:name "SIOP−RTSG panel" .

<http://example.org/entity/SIOP_2001_Study> a ns1:Study ;
    ns1:name "SIOP-2001" .

<http://example.org/entity/SIOP_9301_trial_study> a ns1:study ;
    ns1:name "SIOP 93–01 trial" .

<http://example.org/entity/SIOP_9GPOH_study> a ns1:study ;
    ns1:name "SIOP-9/GPOH" .

<http://example.org/entity/SIOP_Renal_Tumor_Study_Group_organization> a ns1:organization ;
    ns1:name "SIOP Renal Tumor Study Group" .

<http://example.org/entity/SIOP_Renal_Tumour_Study_Group_Group> a ns1:Group ;
    ns1:name "SIOP Renal Tumour Study Group" .

<http://example.org/entity/SIOP_database_database> a ns1:database ;
    ns1:name "SIOP database" .

<http://example.org/entity/San_Marino_Country> a ns1:Country ;
    ns1:name "San Marino" .

<http://example.org/entity/Serbia_Country> a ns1:Country ;
    ns1:name "Serbia" .

<http://example.org/entity/Slovakia_Country> a ns1:Country ;
    ns1:name "Slovakia" .

<http://example.org/entity/Slovenia_Country> a ns1:Country ;
    ns1:name "Slovenia" .

<http://example.org/entity/Smets_A_M_author> a ns1:author ;
    ns1:name "Smets, A. M." .

<http://example.org/entity/Spain_Country> a ns1:Country ;
    ns1:name "Spain" .

<http://example.org/entity/Spreafico_F_author> a ns1:author ;
    ns1:name "Spreafico, F." .

<http://example.org/entity/Springer_Nature_Organization> a ns1:Organization ;
    ns1:name "Springer Nature" .

<http://example.org/entity/Springer_Nature_organization> a ns1:organization ;
    ns1:name "Springer Nature" .

<http://example.org/entity/St_Anna_KinderspitalCCRI_Institution> a ns1:Institution ;
    ns1:name "St. Anna Kinderspital/CCRI" .

<http://example.org/entity/Stage_IIIII_intermediate_risk_Wilms_tumours_Condition> a ns1:Condition ;
    ns1:name "Stage II–III intermediate-risk Wilms tumours" .

<http://example.org/entity/Stage_IV_WT_condition> a ns1:condition ;
    ns1:name "Stage IV WT" .

<http://example.org/entity/Stage_IV_disease_Condition> a ns1:Condition ;
    ns1:name "Stage IV disease" .

<http://example.org/entity/Stage_IV_disease_entity> ns2:is_a_condition_of <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/Sweden_Country> a ns1:Country ;
    ns1:name "Sweden" .

<http://example.org/entity/Switzerland_Country> a ns1:Country ;
    ns1:name "Switzerland" .

<http://example.org/entity/Synchronous_bilateral_Wilms_tumour_stage_V_Subcondition> a ns1:Subcondition ;
    ns1:name "Synchronous bilateral Wilms tumour (stage V)" .

<http://example.org/entity/Tournade_M_F_author> a ns1:author ;
    ns1:name "Tournade, M. F." .

<http://example.org/entity/Tunisia_Country> a ns1:Country ;
    ns1:name "Tunisia" .

<http://example.org/entity/Turkey_Country> a ns1:Country ;
    ns1:name "Turkey" .

<http://example.org/entity/UKW3_trial_study> a ns1:study ;
    ns1:name "UKW3 trial" .

<http://example.org/entity/UKW3_trial_trial> a ns1:trial ;
    ns1:name "UKW3 trial" .

<http://example.org/entity/UK_Childrens_Cancer_and_Leukaemia_Group_UKCCLG_organization> a ns1:organization ;
    ns1:name "UK Children’s Cancer and Leukaemia Group (UKCCLG)" .

<http://example.org/entity/UMBRELLA_Protocol_protocol> a ns1:protocol ;
    ns1:name "UMBRELLA Protocol" .

<http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_Protocol> a ns1:Protocol ;
    ns1:name "UMBRELLA SIOP-RTSG 2016" .

<http://example.org/entity/UMBRELLA_protocol_Protocol> a ns1:Protocol ;
    ns1:name "UMBRELLA protocol" .

<http://example.org/entity/UMBRELLA_protocol_medical_protocol> a ns1:medical_protocol ;
    ns1:name "UMBRELLA protocol" .

<http://example.org/entity/UMBRELLA_protocol_protocol> a ns1:protocol ;
    ns1:name "UMBRELLA protocol" .

<http://example.org/entity/Ukraine_Country> a ns1:Country ;
    ns1:name "Ukraine" .

<http://example.org/entity/United_Kingdom_Country> a ns1:Country ;
    ns1:name "United Kingdom" .

<http://example.org/entity/University_Hospital_Homburg_Institution> a ns1:Institution ;
    ns1:name "University Hospital Homburg" .

<http://example.org/entity/University_Hospital_of_Munich_Institution> a ns1:Institution ;
    ns1:name "University Hospital of Munich" .

<http://example.org/entity/University_Hospital_of_Tuebingen_Institution> a ns1:Institution ;
    ns1:name "University Hospital of Tuebingen" .

<http://example.org/entity/VP16_medication> a ns1:medication ;
    ns1:name "VP16" .

<http://example.org/entity/Verschuur_A_author> a ns1:author ;
    ns1:name "Verschuur, A." .

<http://example.org/entity/Vincristine_medication> a ns1:medication ;
    ns1:name "Vincristine" .

<http://example.org/entity/Warmann_S_W_author> a ns1:author ;
    ns1:name "Warmann, S. W." .

<http://example.org/entity/Weirich_A_author> a ns1:author ;
    ns1:name "Weirich, A." .

<http://example.org/entity/Wilms_Tumours_disease> a ns1:disease ;
    ns1:name "Wilms Tumours" .

<http://example.org/entity/Wilms_tumour_Disease> a ns1:Disease ;
    ns1:name "Wilms tumour" .

<http://example.org/entity/Wilms_tumours_Condition> a ns1:Condition ;
    ns1:name "Wilms tumours" .

<http://example.org/entity/Wilms_tumours_Medical_Condition> a ns1:Medical_Condition ;
    ns1:name "Wilms tumours" .

<http://example.org/entity/actinomycin_D_Drug> a ns1:Drug ;
    ns1:name "actinomycin D" .

<http://example.org/entity/actinomycin_D_Medication> a ns1:Medication ;
    ns1:name "actinomycin-D" .

<http://example.org/entity/actinomycin_D_entity> ns2:used_for <http://example.org/entity/adult_Wilms_Tumours_entity> .

<http://example.org/entity/actinomycin_D_medication> a ns1:medication ;
    ns1:name "actinomycin D",
        "actinomycin-D" .

<http://example.org/entity/adult_Wilms_Tumours_medical_condition> a ns1:medical_condition ;
    ns1:name "adult Wilms Tumours" .

<http://example.org/entity/anaplasia_medical_condition> a ns1:medical_condition ;
    ns1:name "anaplasia" .

<http://example.org/entity/autologous_stem_cell_transplantation_treatment> a ns1:treatment ;
    ns1:name "autologous stem cell transplantation" .

<http://example.org/entity/blastemal_type_tumors_condition> a ns1:condition ;
    ns1:name "blastemal-type tumors" .

<http://example.org/entity/blastemal_type_tumours_Condition> a ns1:Condition ;
    ns1:name "blastemal-type tumours" .

<http://example.org/entity/camptothecins_medication> a ns1:medication ;
    ns1:name "camptothecins" .

<http://example.org/entity/carboplatin_Drug> a ns1:Drug ;
    ns1:name "carboplatin" .

<http://example.org/entity/carboplatin_entity> ns2:used_for <http://example.org/entity/anaplastic_tumors_entity> .

<http://example.org/entity/carboplatin_medication> a ns1:medication ;
    ns1:name "carboplatin" .

<http://example.org/entity/chemotherapy_treatment> a ns1:treatment ;
    ns1:name "chemotherapy" .

<http://example.org/entity/childhood_renal_tumours_Medical_Condition> a ns1:Medical_Condition ;
    ns1:name "childhood renal tumours" .

<http://example.org/entity/clear_cell_sarcoma_of_the_kidney_Medical_Condition> a ns1:Medical_Condition ;
    ns1:name "clear cell sarcoma of the kidney" .

<http://example.org/entity/congenital_mesoblastic_nephroma_Medical_Condition> a ns1:Medical_Condition ;
    ns1:name "congenital mesoblastic nephroma" .

<http://example.org/entity/congenital_mesoblastic_nephroma_entity> ns2:needs <http://example.org/entity/surgery_entity> .

<http://example.org/entity/congenital_mesoblastic_nephroma_medical_condition> a ns1:medical_condition ;
    ns1:name "congenital mesoblastic nephroma" .

<http://example.org/entity/cyclophosphamide_Drug> a ns1:Drug ;
    ns1:name "cyclophosphamide" .

<http://example.org/entity/cyclophosphamide_medication> a ns1:medication ;
    ns1:name "cyclophosphamide" .

<http://example.org/entity/de_Kraker_J_author> a ns1:author ;
    ns1:name "de Kraker, J." .

<http://example.org/entity/diffuse_anaplasia_condition> a ns1:condition ;
    ns1:name "diffuse anaplasia" .

<http://example.org/entity/doxorubicin_Drug> a ns1:Drug ;
    ns1:name "doxorubicin" .

<http://example.org/entity/doxorubicin_Medication> a ns1:Medication ;
    ns1:name "doxorubicin" .

<http://example.org/entity/doxorubicin_medication> a ns1:medication ;
    ns1:name "doxorubicin" .

<http://example.org/entity/etoposide_Drug> a ns1:Drug ;
    ns1:name "etoposide" .

<http://example.org/entity/etoposide_medication> a ns1:medication ;
    ns1:name "etoposide" .

<http://example.org/entity/group_BB_protocol_protocol> a ns1:protocol ;
    ns1:name "group BB protocol" .

<http://example.org/entity/ifosfamide_entity> ns2:causes <http://example.org/entity/nephrotoxicity_entity> .

<http://example.org/entity/ifosfamide_medication> a ns1:medication ;
    ns1:name "ifosfamide" .

<http://example.org/entity/infant_Wilms_Tumours_medical_condition> a ns1:medical_condition ;
    ns1:name "infant Wilms Tumours" .

<http://example.org/entity/irinotecan_medication> a ns1:medication ;
    ns1:name "irinotecan" .

<http://example.org/entity/laparoscopic_surgery_Treatment> a ns1:Treatment ;
    ns1:name "laparoscopic surgery" .

<http://example.org/entity/lymph_node_sampling_procedure> a ns1:procedure ;
    ns1:name "lymph node sampling" .

<http://example.org/entity/malignant_rhabdoid_tumors_medical_condition> a ns1:medical_condition ;
    ns1:name "malignant rhabdoid tumors" .

<http://example.org/entity/malignant_rhabdoid_tumour_of_the_kidney_Medical_Condition> a ns1:Medical_Condition ;
    ns1:name "malignant rhabdoid tumour of the kidney" .

<http://example.org/entity/minimally_invasive_surgery_Treatment> a ns1:Treatment ;
    ns1:name "minimally invasive surgery" .

<http://example.org/entity/nephrectomy_procedure> a ns1:procedure ;
    ns1:name "nephrectomy" .

<http://example.org/entity/nephron_sparing_surgery_NSS_Treatment> a ns1:Treatment ;
    ns1:name "nephron-sparing surgery (NSS)" .

<http://example.org/entity/nephron_sparing_surgery_NSS_procedure> a ns1:procedure ;
    ns1:name "nephron-sparing surgery (NSS)" .

<http://example.org/entity/nephrotoxicity_condition> a ns1:condition ;
    ns1:name "nephrotoxicity" .

<http://example.org/entity/non_Wilms_tumours_Medical_Condition> a ns1:Medical_Condition ;
    ns1:name "non-Wilms tumours" .

<http://example.org/entity/proton_therapy_Treatment> a ns1:Treatment ;
    ns1:name "proton therapy" .

<http://example.org/entity/pulmonary_metastases_Condition> a ns1:Condition ;
    ns1:name "pulmonary metastases" .

<http://example.org/entity/pulmonary_radiotherapy_Treatment> a ns1:Treatment ;
    ns1:name "pulmonary radiotherapy" .

<http://example.org/entity/radical_tumor_nephrectomy_procedure> a ns1:procedure ;
    ns1:name "radical tumor nephrectomy" .

<http://example.org/entity/radiotherapy_Treatment> a ns1:Treatment ;
    ns1:name "radiotherapy" .

<http://example.org/entity/radiotherapy_treatment> a ns1:treatment ;
    ns1:name "radiotherapy" .

<http://example.org/entity/relapsed_group_CC_patient_group> a ns1:patient_group ;
    ns1:name "relapsed group CC" .

<http://example.org/entity/renal_cell_carcinoma_Medical_Condition> a ns1:Medical_Condition ;
    ns1:name "renal cell carcinoma" .

<http://example.org/entity/surgery_entity> ns2:guided_by <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/surgery_treatment> a ns1:treatment ;
    ns1:name "surgery" .

<http://example.org/entity/surgical_excision_treatment> a ns1:treatment ;
    ns1:name "surgical excision" .

<http://example.org/entity/topotecan_medication> a ns1:medication ;
    ns1:name "topotecan" .

<http://example.org/entity/van_den_Heuvel_Eibrink_M_M_author> a ns1:author ;
    ns1:name "van den Heuvel-Eibrink, M. M." .

<http://example.org/entity/vincristine_Medication> a ns1:Medication ;
    ns1:name "vincristine" .

<http://example.org/entity/vincristine_and_actinomycin_D_Treatment_Regimen> a ns1:Treatment_Regimen ;
    ns1:name "vincristine and actinomycin D" .

<http://example.org/entity/vincristine_and_actinomycin_D_plus_doxorubicin_treatment> a ns1:treatment ;
    ns1:name "vincristine and actinomycin D plus doxorubicin" .

<http://example.org/entity/vincristine_and_actinomycin_D_treatment> a ns1:treatment ;
    ns1:name "vincristine and actinomycin D" .

<http://example.org/entity/vincristine_entity> ns2:used_for <http://example.org/entity/adult_Wilms_Tumours_entity> .

<http://example.org/entity/vincristine_medication> a ns1:medication ;
    ns1:name "vincristine" .

<http://example.org/entity/whole_abdominal_radiotherapy_Treatment> a ns1:Treatment ;
    ns1:name "whole-abdominal radiotherapy" .

<http://example.org/entity/whole_lung_irradiation_Treatment> a ns1:Treatment ;
    ns1:name "whole-lung irradiation" .

<http://example.org/entity/wwwsiop_rtsgeu_Website> a ns1:Website ;
    ns1:name "www.siop-rtsg.eu" .

<http://example.org/entity/SIOP2001_entity> ns2:compared_to_UMBRELLA_protocol_in_terms_of_cumulative_dose <http://example.org/entity/doxorubicin_entity> .

<http://example.org/entity/UKW3_trial_entity> ns2:tested <http://example.org/entity/Actinomycin_D_and_Vincristine_entity> .

<http://example.org/entity/cyclophosphamide_entity> ns2:used_for <http://example.org/entity/anaplastic_tumors_entity> .

<http://example.org/entity/Wilms_Tumours_entity> ns2:is_treated_in <http://example.org/entity/UMBRELLA_Protocol_entity> .

<http://example.org/entity/adult_Wilms_Tumours_entity> ns2:managed_by <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/doxorubicin_entity> ns2:used_for <http://example.org/entity/adult_Wilms_Tumours_entity> .

<http://example.org/entity/UMBRELLA_protocol_entity> ns2:adopts_treatment_from <http://example.org/entity/SIOP2001_entity> ;
    ns2:facilitates <http://example.org/entity/European_Expert_Paediatric_Oncology_Reference_Network_for_Diagnostics_and_Treatment_entity> ;
    ns2:guides <http://example.org/entity/SIOP_Renal_Tumour_Study_Group_entity> ;
    ns2:supports_initiatives_of <http://example.org/entity/Innovative_Therapies_for_Children_with_Cancer_consortium_entity> .

